Welcome to our dedicated page for Agrify SEC filings (Ticker: AGFY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The AGFY SEC filings page on Stock Titan provides access to regulatory documents for Agrify Corporation, which a later Form 8-K identifies as having changed its name to RYTHM, Inc., with common stock listed on the Nasdaq Capital Market under the symbol RYM. These filings offer detailed insight into the company’s changing business mix, capital structure, and brand-focused strategy in the cannabis and hemp sectors.
Among the documents, Form 8-K reports describe key corporate events. An October 2025 8-K explains that the company, formerly known as Agrify Corporation, is now RYTHM, Inc. and that its legacy extraction business has been reclassified as discontinued operations under Accounting Standard Codification Topic 205-20 for specified historical periods. Another 8-K filed in August 2025 outlines a Purchase Agreement under which the company acquired all equity interests in VCP IP Holdings, LLC from an indirect subsidiary of Green Thumb Industries Inc., noting that VCP’s assets consist primarily of intellectual property rights to brands including RYTHM, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green.
The same August 2025 filing also describes a Trademark and Recipe License Agreement granting a Green Thumb subsidiary license rights to use certain intellectual property associated with the acquired brands in exchange for a monthly license fee based on product sales. It further details secured convertible notes issued to a Green Thumb subsidiary and other investors, including maturity, interest terms, conversion features into common stock or pre-funded warrants, and ranking relative to other indebtedness.
Earlier filings and press releases referenced in the filings discuss the company’s historical focus on cultivation and extraction solutions and later transactions such as the sale of its cultivation business and financing arrangements. On Stock Titan, these SEC documents are paired with AI-powered summaries that highlight items such as discontinued operations treatment, brand and IP acquisitions, financing structures, and name and ticker changes, helping readers quickly understand the implications of lengthy filings without replacing the underlying official text.
RYTHM, Inc. files its annual report describing a transformed business focused on hemp-derived THC beverages and licensed cannabis brands after exiting cultivation and extraction. The company changed its name from Agrify Corporation and now relies heavily on shared services from Green Thumb affiliates.
RYTHM highlights major secured convertible notes totaling
The report stresses substantial regulatory risk: the 2026 Appropriations Act would, after a 365‑day grace period, effectively prohibit its current hemp-derived THC products and could trigger repurchase rights over key brand IP. Extensive risk factors also cover federal and state enforcement uncertainty, dependence on Green Thumb-related parties, competitive pressure, and the potential need for additional financing to meet debt obligations.
RYTHM, Inc. received an updated Schedule 13D/A showing that a group of related entities led by Green Thumb Industries Inc. collectively reports beneficial ownership of 13,211,928 shares of common stock, or 49.99% of the company, based on 2,149,148 shares outstanding as of March 1, 2026.
This stake includes previously acquired common shares, secured convertible notes and multiple series of warrants, many of which are subject to 4.99% or 49.99% beneficial ownership limits and Nasdaq-related conversion and exercise restrictions. On March 1, 2026, the company also issued new Interest Warrants for up to 57,377 shares as an interest payment under a May 2025 note.
The reporting group states that its actions may be deemed to have a control purpose and indicates it may engage with management, the board and other shareholders on capitalization, ownership structure, board composition, and potential business combinations or dispositions, as well as consider buying or selling additional securities.
RYTHM, Inc. reported that RSLGH, LLC, an entity indirectly wholly owned by Green Thumb Industries Inc., acquired 57,377 Pre-Funded Warrants as payment of interest on a May 25, 2025 convertible note. These warrants carry a 49.99% beneficial ownership cap and their exercise is subject to stockholder approval under applicable Nasdaq listing rules, to the extent required. After this interest payment, RSLGH holds a total of 68,750 Pre-Funded Warrants in RYTHM, Inc.
RYTHM, Inc. reported rapid growth in hemp-derived THC brands alongside continued losses for the quarter and year ended December 31, 2025. Full-year revenue rose to
In the fourth quarter, revenue reached
RYTHM ended 2025 with
Double or Nothing LLC and its members report a significant passive stake in , Inc. As of December 31, 2025, they may be deemed to beneficially own 227,995 shares of common stock, representing 9.9% of the outstanding class.
This includes 211,386 shares of common stock and 133,109 shares underlying pre-funded warrants that cannot be exercised above a 9.99% ownership cap. Joel Gott and Charles Bieler, as members of Double or Nothing LLC, may be deemed beneficial owners but each disclaims beneficial ownership beyond any pecuniary interest. They certify the holdings are not for changing or influencing control of the issuer.
RYTHM, Inc. reported an insider transaction by its Interim CEO and director on a Form 4 dated 11/19/2025. The filing shows that 17,526 shares of common stock were withheld by the company at a price of $19.19 per share to cover tax withholding on the vesting of restricted stock units held by the executive, which is a non‑open‑market transaction coded as “F.”
After this tax withholding, the reporting person beneficially owns 65,849 shares of RYTHM common stock directly and an additional 420 shares indirectly through a daughter. This reflects routine equity compensation administration rather than a discretionary sale of shares into the market.
RYTHM, Inc. reported third‑quarter 2025 results reflecting its shift to hemp-derived THC brands and licensing. Revenue from continuing operations was $4.043 million, producing gross profit of $1.375 million. Operating loss from continuing operations was $8.888 million, and net loss totaled $10.665 million.
The company completed brand IP deals in 2025, acquiring MC Brands for $5.1 million and VCP brand rights for $50.0 million, expanding the RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon’s, and Good Green portfolio. Discontinued operations include the prior Extraction and Cultivation businesses, with a $3.534 million gain on the Extraction exit year‑to‑date.
RYTHM ended the quarter with $35.573 million in cash and cash equivalents and reported $61.497 million of intangible assets. Convertible notes and other borrowings totaled scheduled principal of $90.621 million, including $82.0 million related‑party notes. Stockholders’ equity was $11.722 million. The company changed its name and Nasdaq ticker to RYM effective September 2025.
RYTHM, Inc. filed an 8-K stating it furnished a press release announcing financial results for the quarter ended September 30, 2025. The company furnished the release under Item 2.02, and it is attached as Exhibit 99.1.
The company noted this information is not deemed “filed” for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless specifically stated.
RYTHM, Inc. reported an equity award to its Chief Financial Officer on a Form 4. On 11/03/2025, the officer acquired 6,000 shares of Common Stock at $0, recorded as a grant of restricted stock units under the 2022 Omnibus Equity Incentive Plan. Following the transaction, the officer beneficially owned 6,000 shares directly. The RSUs vest in two equal tranches: 50% on March 15, 2027 and 50% on June 15, 2028.
Green Thumb Industries Inc. (GTBIF) and affiliate RSLGH, LLC filed a Form 4 reporting a debt-to-equity move on November 3, 2025. RSLGH converted a November 2024 convertible note into pre-funded warrants.
The conversion covered $10,000,000 of principal plus $175,000 of accrued interest, issuing 3,222,997 pre-funded warrants at a warrant conversion price of $3.157. The warrants are exercisable at $0.001 per share. A 49.99% beneficial ownership limitation applies, and exercise is also subject to stockholder approval under applicable Nasdaq listing rules, to the extent required.